Glenn Pierce - Jan 13, 2022 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
Interim CSO, Director
Signature
/s/ Robert Hesslein, as Attorney-in-Fact for Glenn Pierce
Stock symbol
VYGR
Transactions as of
Jan 13, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 07:05 PM
Previous filing
Jun 21, 2021
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Award $0 +26.3K $0.00 26.3K Jan 13, 2022 Direct F1
holding VYGR Common Stock 5K Jan 13, 2022 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VYGR Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jan 13, 2022 Common Stock 50K $2.85 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock issuable under an aggregate of 26,300 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, January 13, 2022. 100% of the shares of common stock underlying the RSU award vest on the six-month anniversary of such vesting commencement date, subject to the Reporting Person's continued service as a director, officer, or otherwise.
F2 The securities are directly held by the Pierce Family Trust, dated October 13, 1993 (the "Pierce Family Trust"). The Reporting Person's immediate family members are beneficiaries of the Pierce Family Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
F3 This stock option was issued pursuant to the Plan. 1/5th of the shares of common stock underlying the option vest on each of February 12, 2022, March 12, 2022, April 12, 2022, May 12, 2022 and June 2, 2022, subject to the Reporting Person's continued service as an interim executive officer.

Remarks:

Exhibit 24.1: Limited Power of Attorney